BDH Industries Ltd. – Company Report
1. Company Overview
BDH Industries Ltd., established in 1990 and headquartered in Mumbai, Maharashtra, is an Indian pharmaceutical and chemical products company with a notable presence in both domestic and international markets. It specializes in manufacturing, formulating, and exporting bulk drugs (APIs), pharmaceutical formulations, and specialty chemicals. The company serves the pharmaceutical, nutraceutical, veterinary, and chemical industries, maintaining a strong compliance framework with Indian and global regulatory bodies.
BDH Industries operates modern manufacturing facilities certified by WHO-GMP, with an emphasis on research-driven product development, stringent quality assurance, and environmental consciousness. Over the years, the company has expanded its reach to over 20 countries, underpinned by a robust supply chain, skilled workforce, and a customer-centric approach.
- Incorporated: 1990
- Headquarters: Mumbai, Maharashtra, India
- Certifications: WHO-GMP, ISO 9001:2015
- Core Focus: Active pharmaceutical ingredients (APIs), finished formulations, specialty chemicals, and contract manufacturing
- Export Markets: 20+ countries across Africa, Asia, Latin America, and CIS
- Market Capitalization (July 2025): Approximately ₹226 crore
- Key Leadership: Board and management with decades of industry expertise
2. Products and Services
BDH Industries Ltd. offers a diversified product portfolio aligned with high-quality standards and broad therapeutic utility:
Active Pharmaceutical Ingredients (APIs):
Wide range of APIs for segments such as anesthetics, antifungals, anti-infectives, and CNS actives. The company is recognized for producing hard-to-make specialty APIs for domestic and export markets.Pharmaceutical Formulations:
Tablets, capsules, injectables, ointments, and oral liquids in categories including antibiotics, analgesics, antihistamines, and multivitamins. Custom formulations are supplied to institutional buyers and government agencies.Specialty Chemicals:
Products catering to pharma, nutraceutical, and veterinary use, including excipients and premix blends.Contract Manufacturing & Export Services:
BDH provides contract research and manufacturing for leading Indian and international pharmaceutical companies, delivering both bulk ingredients and finished dosage forms.Sustainability Initiatives:
The company incorporates green chemistry principles and renewable energy in its manufacturing, underscoring a commitment to ecological balance and responsible production.
3. Recent News & Financial Performance
Wind Power Plant Commissioning (2024)
BDH Industries Limited has successfully commissioned its wind power plants in Jaisalmer, Rajasthan—comprising two units of 0.8 MW each (total 1.6 MW). The plants, now operational, will generate renewable power under the open access/third-party sale mode as per the commercial agreement with Jodhpur DISCOM dated 23 February 2024, officially communicated on 26 February 2024. This green initiative underscores BDH’s commitment to sustainability, cost efficiency, and clean energy in its industrial operations.
Recent Developments:
- Increased focus on renewable energy integration to further minimize carbon footprint
- Ongoing expansion in export markets with regulatory approvals for new geographies
- Continued investments in plant modernization and technology upgrades to maintain superior product quality and regulatory compliance
4. Financial Performance (FY2025)
| Metric | FY2025 |
|---|---|
| Revenue from Operations | ₹66.51 crore |
| Net Profit | ₹9.27 crore |
| Operating Profit | ₹11.6 crore |
| Operating Profit Margin | 18% |
| Net Profit Margin | ~13% |
| Earnings Per Share (EPS) | ₹16.1 |